Literature DB >> 26628599

Is Disease Activity in Rheumatoid Arthritis during Pregnancy and after Delivery Predictive for Disease Activity in a Subsequent Pregnancy?

Hilal Ince-Askan1, Johanna M W Hazes2, Radboud J E M Dolhain2.   

Abstract

OBJECTIVE: To determine whether disease activity in women with rheumatoid arthritis (RA) in 1 pregnancy is predictive for disease activity in a subsequent pregnancy.
METHODS: In the Pregnancy-induced Amelioration of Rheumatoid Arthritis study, there are prospective data on 27 patients who participated twice. Improvement and deterioration is determined by changes in the Disease Activity Score in 28 joints.
RESULTS: Only 4 patients (14.8%) had comparable disease courses in both pregnancies, whereas treatment remained mostly similar. In contrast, a flare postpartum after the first pregnancy was predictive for a flare after the second pregnancy (p = 0.003).
CONCLUSION: RA disease course in following pregnancies cannot be predicted based upon previous pregnancies. However, a flare postpartum seems to predict subsequent flares.

Entities:  

Keywords:  DISEASE ACTIVITY; PREGNANCY; RHEUMATOID ARTHRITIS

Mesh:

Year:  2015        PMID: 26628599     DOI: 10.3899/jrheum.150565

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

1.  Altered DNA methylation in children born to mothers with rheumatoid arthritis during pregnancy.

Authors:  Hilal Ince-Askan; Pooja R Mandaviya; Janine F Felix; Liesbeth Duijts; Joyce B van Meurs; Johanna M W Hazes; Radboud J E M Dolhain
Journal:  Ann Rheum Dis       Date:  2019-05-29       Impact factor: 19.103

2.  Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis.

Authors:  Maria Chiara Gerardi; Francesca Crisafulli; Antía García-Fernandez; Daniele Lini; Chiara Bazzani; Ilaria Cavazzana; Matteo Filippini; Micaela Fredi; Roberto Gorla; Maria Grazia Lazzaroni; Cecilia Nalli; Marco Taglietti; Andrea Lojacono; Francesca Ramazzotto; Cristina Zanardini; Sonia Zatti; Franco Franceschini; Angela Tincani; Laura Andreoli
Journal:  Front Pharmacol       Date:  2022-08-03       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.